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Abstract
Polyparasitism is common in the developing world. We have previously demonstrated that schistosomiasis-positive (SP)
Malian children have age-dependent protection from malaria compared to matched schistosomiasis-negative (SN) children.
Evidence of durable immunologic memory to malaria antigens is conflicting, particularly in young children and the effect of
concomitant schistomiasis upon acquisition of memory is unknown. We examined antigen-specific B memory cell (MBC)
frequencies (expressed as percentage of total number of IgG-secreting cells) in 84 Malian children aged 4–14 to malaria
blood-stage antigens, apical membrane antigen 1 (AMA-1) and merozoite surface protein 1 (MSP-1) and to schistosomal
antigens, Soluble Worm Antigenic Preparation (SWAP) and Schistosoma Egg Antigen (SEA), at a time point during the
malaria transmission season and a follow-up dry season visit. We demonstrate, for the first time, MBC responses to S.
haematobium antigens in Malian children with urinary egg excretion and provide evidence of seasonal acquisition of
immunologic memory, age-associated differences in MBC acquisition, and correlation with circulating S. haematobium
antibody. Moreover, the presence of a parasitic co-infection resulted in older children, aged 9–14 years, with underlying S.
haematobium infection having significantly more MBC response to malaria antigens (AMA1 and MSP1) than their age-
matched SN counterparts. We conclude that detectable MBC response can be measured against both malaria and
schistosomal antigens and that the presence of S. haematobium may be associated with enhanced MBC induction in an age-
specific manner.
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Introduction
The acquisition of immunologic memory depends upon a rapid
and specific recall response after re-exposure to an antigen. A
component of immunological memory that is central to long-term
humoral immunity is the memory B cell response (MBC). MBC
differentiate into antibody-secreting plasma cells that enable long-
term maintenance of serum antibody levels. Long-lived plasma
cells (LLPC) may reside in sequestered niches with limited space
such as the bone marrow. Newly-generated plasmablasts would
periodically displace these LLPC resulting in a slow decline of the
compartment over time (i.e. the plasma cell niche competition
model) or programming of individual plasma cells at the time of
induction may determine differential lifespan (the plasma cell
imprinted lifespan model) (Reviewed by Slifka) [1]. The sustained
generation of antibody depends upon either intermittent or
persistent antigen exposure, as seen in repeated or chronic
infections, leading to MBC differentiation into effector plasma
cells, or polyclonal antigen-independent differentiation of MBC
via Toll-like receptor (TLR) or T-cell dependent bystander
activation [2]. Very little is known about the acquisition of
immunologic MBC to parasites. Knowledge gained regarding the
acquisition of memory to parasites, are of great importance for the
development of novel vaccines to both malaria and helminthes.
Evidence of durable immunologic memory to malaria antigens
is mixed, particularly in young children, where repetitive and
ongoing exposure to malaria is required to achieve and maintain
immunity [3,4]. Maternally-derived antibody to P. falciparum
protects infants in the early months of life [5,6] after which,
acquisition of antibody is critical to naturally-acquired blood-stage
malaria immunity [7,8]. It has been assumed that because
antibodies are short-lived and decrease rapidly after infection,
long-term immunologic memory acquisition may be inefficient.
MBC to blood-stage malaria antigens were measured in a highly
malaria-endemic area but at a reduced level compared to a more
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studies demonstrated long-lived MBC responses to P. falciparum
(Pf) and P. vivax (Pv) antigens in an area of low-endemicity [10], as
well as an expanding Pf MBC compartment elicited by repeated
malaria exposure [11].
In chronic human Shistosoma spp. infections, antibody and age
correlate with resistance to re-infection [12–14]. S. haematobium
prevalence has risen sharply in West Africa, due in large part to
the building of hydroelectric dams [15]. Chronic egg-laying
schistosomes exert a persistent stimulatory effect on the host
immune system, chiefly to egg antigens. S. mansoni egg production
correlates with increased levels of the C3d component of
complement (B cell receptor, CD21 ligand) [16], and enhances
TLR9 responsiveness of bone marrow-derived Th2-primed
macrophages [17], both of which have been shown to be potent
inducers of MBC [18,19]. However, to our knowledge, MBC to
Schistosoma spp. have never been measured in an endemic
population.
We and others have shown that S. haematobium infection to
protects against uncomplicated Pf malaria in an age-specific
manner in West African children [20,21]. Both parasitic diseases
elicit stage-specific immunological responses in the human host
[22–24]; however, dual infection may disrupt immunologic
homeostasis and either enhance or abrogate pathogenicity [25–
28]. We report here on the appearance and persistence of MBC
over the course of a single malaria transmission season and
measure MBC to both blood-stage malaria antigens and, for the
first time, S. haematobium antigens. Given that one parasitic
infection may immunologically perturb the immune responsive-
ness to another infection in the human host, we also examined the
effect of concomitant schistosomiasis upon the acquisition of
memory to malaria.
Methods
Specimens and Surveillance
Bandiagara (pop. ,13,600) is located in Mali, West Africa and
has intense seasonal transmission (July-December) of P. falciparum
malaria and S. haematobium. The entomologic inoculation rate is
20–60 infected bites per month during peak transmission, falling to
near zero during the dry season. Children experience a mean of
1.54 symptomatic malaria episodes per year [29]. S. haematobium
prevalence is 50% by the age of 14 years [20] with peak
acquisition between the ages of 6–14 years [15]. The study was
conducted over two sequential malaria seasons in 2002–2003 (half
the matched children were enrolled in each year). No difference in
rainfall pattern or malaria illness was noted between the two years.
Study details have previously been reported [20,25]. Briefly,
baseline demographic data, urine samples and stool samples were
collected in all children at screening. Morning urine samples were
obtained and 10 milliliters filtered through NucleoporeH (Acton,
MA) filters with WhatmannH filter paper (22 mm). Filter papers
were stained with 5% Ninhydrin and examined for the presence of
S. haematobium eggs when dry. Each individual submitted 3
sequential morning urine samples to improve sensitivity. Stool
samples were collected and processed using the Kato-Katz method
for parasite detection. Slides were read and intestinal parasites
quantified. All children displaying symptomatic effects related to
underlying S. haematobium infection (gross hematuria, renal
insufficiency, peripheral edema) were offered praziquantelH
treatment and excluded (n=6). Exclusion criteria were presence
of S. mansoni eggs in stool, evidence of acute or chronic illness,
participation in prior malaria vaccine studies and pregnancy.
Previous studies performed in Bandiagaran children from revealed
no detectable filarial infections (i.e., Loa loa, Onchocerca volvulus, or
Wuchereria bancrofti). HIV prevalence is less than 2% among adults
in Mali and this is found primarily in commercial sex workers.
Study children were not tested individually for these infections
although every attempt was made to only enroll healthy
individuals. Children aged 4–14 years of age, diagnosed as having
asymptomatic S. haematobium infection (SP), were matched by age,
gender and residence to a child without schistosomiasis (SN) prior
to the start of malaria transmission. Children were followed
weekly, at a scheduled follow-up visit, over the malaria transmis-
sion season (25 weeks) and at a dry season follow-up appointment
(,9 months after enrollment at a time when standing water pools
had dried and schistosoma transmission had ceased). The primary
endpoint of the clinical study was time to first clinical malaria
episode. A clinical episode of malaria was defined as P. falciparum
parasitemia and axillary temperature $37.5uC on active surveil-
lance, or parasitemia and symptoms leading to treatment-seeking
behavior in the absence of other clear cause on passive
surveillance. Clinic personnel were available 24 hours-a-day
throughout study duration to detect, examine and treat malaria
episodes. All children were pre-treated with albendazole to
eliminate concomitant helminth infections and study samples
were drawn at the time of their first clinical malaria episode (or at
study week 25/Day 175 in the absence of a clinical infection) and
again at the final dry season appointment. Monthly hemoglobin
levels were checked to track evidence of anemia. Children were
optimally treated for schistosomiasis with praziquantel at the final
appointment (eight weeks after standing water pools dried, to
ensure maturation of underlying schistosomula in individuals)
Ethics
The trial was conducted in compliance with the Declaration of
Helsinki. Study protocols were reviewed and approved by the
University of Bamako’s Institutional Review Board (IRB) as well as
the University of Maryland IRB. Village permission to conduct
research was obtained from village chiefs, government officials and
traditional healers prior to study initiation. Individual written
informed consent was obtained from the parent or legal guardian
of each child prior to screening and enrollment. S. haematobium is a
chronic disease in the absence of therapy. Genito-urinary
inflammation secondary to migrating eggs is usually sustained
over decades although the majority of individuals never experience
clinical morbidity. After consultation with experts and IRBs, a
nine-month interval between detection and treatment of asymp-
tomatic infections was felt to be safe and reasonable. Schistoso-
miasis transmission is seasonal in Mali. The efficiency of
transmission rises in the dry season when standing water
evaporates and cercariae are concentrated. Immature schistosom-
ula are resistant to praziquantel and require eight weeks for larval
maturation. Premature treatment of infections and treatment
during ongoing transmission ensures a high degree of treatment
failure and/or re-infection [30]. The consequences of treatment in
endemic populations with ongoing, frequent parasitic exposure are
unclear. Acquired partial resistance to infection occurs with down-
regulation of inflammatory response to parasites [31,32]. Treat-
ment may interrupt this partial resistance and trigger a surge of
immunologically mediated disease upon re-exposure. We pro-
posed a measured approach ensuring the best clinical cure and
least harm to our study subjects. Although a small risk of acute
inflammation due to egg migration existed, all subjects were
monitored for evidence of gross hematuria or symptoms of
genitourinary pathology and were treated immediately with
praziquantel (40 mg/kg) therapy in the event that symptoms
developed.
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Patient whole blood (5–10 mL) was collected at the study clinic
into sterile Eppendorf and EDTA tubes on admission, prior to
institution of anti-malarial therapy, and immediately refrigerated.
Serum was processed as previously described [25]. Blood was
processed by density centrifugation, within two hours of acquisi-
tion, utilizing lymphocyte separation medium (ICN Biomedical
Inc, Aurora, OH) following standard techniques [33]. Peripheral
blood mononuclear cells (PBMC) were resuspended in media and
linear-rate frozen using isopropyl alcohol containers (Nalgene,
USA) to–70uC overnight at the field site before next day
placement in vapor-phase liquid nitrogen and transfer to the
University of Maryland at Baltimore. Samples for this experiment
were randomly chosen from the pool of samples that had at least
10.0610
6 cells as well as adequate quantity of sera for each child at
a both the wet and dry season time points (n=168). An
investigator unblinded to the age of the study sample participants,
randomly chose age-matched samples from the samples meeting
defined criteria (n=84). The wet and dry season time points were
run simultaneously by blinded investigators.
Antigen
Soluble egg antigen (SEA) and soluble worm antigen protein
(SWAP) specific for S. haematobium were obtained through the
Schistosome Related Reagent Repository (SR3) under the
direction of Dr. Fred Lewis and sponsored by the National
Institute of Allergy and Infectious Disease. Apical membrane
antigen 1 (AMA1) [34] and merozoite surface protein 1 (42) were
kindly donated by the Walter Reed Armed Institutes of Research
(WRAIR). The malaria antigens were chosen because they were
previously the foundation of several vaccine studies at the Malian
field site.
PBMC Expansion
PBMC expansion was performed as described previously
[35,36]. PBMC were thawed, washed and expanded for 5 days
at 37uC, 5% CO2, in 6-well sterile plates (5610
5 cells/well) in a
mitogen broth composed of 1/100,000 pokeweed mitogen (PWM)
(Emory University), 50 mM b-mercaptoethanol (b-Me) (Sigma-
Aldrich, St. Louis, MO), 6 mg/mL CpG-2006 (Qiagen/Operon,
Huntsville, AL) and 1/10,000 Staphylococcus aureus Cowan (SAC)
(Sigma-Aldrich, St. Louis, MO) in cRPMI in a total volume of
6 mL/well.
Memory B Cell Assays
96-well ELISpot MAHA (Millipore, Billerica, MA) plates were
coated in triplicate with AMA1 (5 mg/mL), MSP119 (10 mg/mL),
SEA (10 mg/mL), SWAP (10 mg/mL), tetanus toxoid (5 mg/mL)
and total goat anti-human IgG (5 mg/mL) in phosphate buffered
saline (PBS) overnight at 4uC, blocked with 1% bovine serum
albumin (BSA) (Sigma) in RPMI for 2 h at room temperature
(RT), washed with PBS, and incubated with 2610
5 expanded
PBMC/well for wells coated with malaria or schistosoma antigens
or tetanus toxoid. Dilutions for IgG wells were performed in
sextuplet in serial two-fold dilutions starting at 10,000 cells/well
and continuing to 1,250 cells/well using an optimized protocol.
Cells were incubated for 6 h at 37uC, 5% CO2, washed with
ddH2O followed by PBS+0.05% Tween 20 (PBST) and incubated
with mouse anti-human pan-IgG-biotin conjugate antibody
(Hybridoma Reagent Laboratory, Baltimore, MD) overnight at
4uC. Cells were washed with PBST, labeled with 1:1000
horseradish peroxidase (HRP) conjugated Avidin D (Vector
Laboratories, Burlingame, CA) for 1 h at RT. Cells were washed,
stained with 3-Amino-9-ethylcarbazole (AEC) (Calbiochem, Bill-
erica, MA) for 15 minutes at RT before the reaction was stopped
with ddH2O. ELISpots were read using an automated reader
(ImmunospotH, Cellular Technology Ltd.). The final results are
reported as the ratio of spot forming cells (SFC)/10
6 expanded
cells vs. total IgG SFC/10
6 expanded cells henceforth termed
antigen specific cell (ASC) ratio. Values .0.01 were considered
positive.
Elisa
Antibody Levels were Measured in Sera Using Optimized
Standard Enzyme-Linked Immunosorbent Assay. (ELISA)
assay on all clinical samples. Wells in Falcon Pro-Bind 96-well
plates were coated with antigen (0.5 mg/mL AMA1, 1 mg/mL
MSP1, 2 mg/mL SEA and 5 mg/mL SWAP) for 3 h, washed
and blocked with PBS containing 0.05% Tween 20 and 10%
nonfat dried milk. Sera samples, diluted to a concentration of
1:10,000 for AMA1, 1:5000 for MSP1, 1:1000 for SEA and
SWAP, were plated in duplicate, and developed with
1:5000 HRP-conjugated goat anti-human IgG (KPL, Inc.,
Gaithersburg, MD) followed by TMB substrate solution (KPL,
Inc., Gaithersburg, MD). If necessary, experiments were
repeated with sera diluted a further 10-fold for accurate
calculation of OD values. Phosphoric acid 1 M was used to
stop the reaction and the optical density (OD) was read at
450 nm after 20 minutes. Background ODs from uncoated wells
were subtracted from those of antigen-coated wells to adjust for
nonspecific binding. Lower limits of detection were set at
dilutions of 1:500 for AMA1, 1:250 for MSP1, and 1:50 for
SEA and SWAP. Sera from malaria-naive volunteers from the
United States were used as negative controls and pooled sera
from 10 local Malian adults (with known malaria episodes
within 60 days prior to sera collection) were used as positive
controls for both malaria and schistosoma antigens. The
prevalence for S. haematobium is .50% in adults from
Bandiagara and all individuals have seasonal exposure to
malaria. A pool of sera derived from hyperimmune Malian
adults served as a positive control. A pool of sera from
unexposed U.S. adults served as a negative control as we could
not be sure that any residents of Mali would be true negative
controls. Sera differing in value by .20% in one or more of the
replicate wells were retested.
Flow Cytometry Staining and Analysis
Expanded and unexpanded PBMC were stained with
fluorochrome-labeled monoclonal mouse anti-human antibodies
against surface antigens (CD3-Energy Coupled Dye (ECD,
Beckman Coulter, clone UCHT1), CD19-phycoerythrin (PE)-
Cy5 (Beckman Coulter, clone Tu ¨K4), CD27-Alexa 700 (Beck-
man Coulter Custom Conjugate, Clone 1A4CD27), CD38-
allophycocyanin (APC) (BD Biosciences, clone HIT2), and
CD14-Pacific Blue (clone Tu ¨K4). Cells were washed and fixed
in 1% paraformadehyde. Cells were analyzed using a MoFlo
flow cytometer/cell sorter system (Beckman Coulter). List-mode
data files were analyzed using WinList 7.0 3D (Verity Software
House, Topsham, ME) software. An amine reactive dye (ViViD,
Invitrogen, Oregon) was used as a dead cell discriminator and
doublets/aggregates were subtracted from analysis. Gate place-
ment was determined with the aid of Fluorescence Minus One
(FMO) controls.
Statistical Analysis
To ensure that the expansion of PBMC was adequate to allow
for the detection of low numbers of antigen-specific MBC, we
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10
6 expanded cells (arbitrarily defined as the bottom 10
th
percentile of IgG SFC detected in experiments) [37]. Two samples
were eliminated as a result of this criterion. The mean number of
SFC from triplicate runs minus the number of spots from a control
well (PBS) was used in the statistical analysis. The limit of detection
(LOD) was defined as 1 antigen-specific SFC per well, which
corresponded to 10 SFC per 10
6 mononuclear cells when seeding
200,000 cells per well., Positive responses were defined as those
that exceeded a threshold level of 0.01%; this cut off was defined
by taking into the account the LOD (10 antigen-specific SFC/
10
6 PBMC) and the median total IgG SFC (51,000/106 PBMC)
obtained during assay validation with study specimens (0.0098
rounded up to 0.01%) [37].
Statistical analysis was performed on GraphPad Prism 5
(Graphpad Software, Inc., San Diego, CA) and demographic
and immunologic data were stratified and evaluated by season,
schistosomiasis status and age stratification (age 4–8 and 9–14
years). Mann-Whitney rank sum analysis was used for continuous
data not normally distributed and two-sided Student’s t-test for
paired seasonal data. x
2 analysis, using Fisher’s exact test (two-
tailed) as appropriate, was performed for categorical data.
Spearman rank correlation coefficient was calculated utilizing
GraphPad Prism 5. Multivariable Cox regression analysis
controlling for age and schistosoma status was utilized for time
to event analysis. A significance level of P#0.05 was considered
statistically significant. Adjustments were not made for multiple
comparisons.
Results
Study Population
PBMC from 84 children aged 4–14 years (mean: 8.5 years) were
examined. Demographic data of children determined to be S.
haematobium-positive (SP) or S. haematobium-negative (SN) are
depicted in Table 1. Among these, 54 were SP children (40 of
whom developed malaria and 14 who did not acquire malaria
during the transmission season) and 30 were SN children. Very
few SN children remained malaria-free throughout the malaria
transmission season and were not analyzed as a separate group. All
children residing in Bandiagara are exposed to and likely acquire
malaria many times over their lifetime [29], and no difference in
antibody titer or MBC response was noted between SP children
who had or had not developed malaria during the study period for
any antigen in any age group (Table S1). Therefore, study results
were combined into a single SP group. Samples were excluded if
the viability or quantity of PBMC was insufficient or due to lack of
detectable total IgG spots (N=2). The mean PBMC viability after
thaw was calculated as 86.3%. We previously reported on the
finding of age-specific protection against the acquisition of malaria
in SP children aged 4–8 years [20], so demographic and
immunologic data were stratified and evaluated by age group in
this study subset. No statistical differences were noted between age
groups for SP children in the amount of eggs excreted per 10 ml
aliquot of urine, the number of malaria episodes experienced or
the time to first clinical malaria episode. SP children who
developed malaria had a statistically longer time to first clinical
malaria episodes (76 vs. 26 days, P,0.0001), and reduced total
clinical malaria episodes (1.5 vs. 2.1, P=0.002) as compared to
age-matched SN children but similar levels of parasite density
measured at the time of the first clinical malaria episode. There
were no differences in the amount of eggs excreted between SP
children who developed malaria and SP children who did not
develop malaria in a single transmission season.
Memory B cell Response to Malaria Antigens
Paired PBMC sample obtained at two time points (malaria
transmission (wet) season and dry season) were examined in all
children (Table 2, Figure 1A–C). The ASC ratio was calculated
measuring detectable AMA1- and MSP1-specific MBC and
expressed as either 1) a discrete value or 2) as a positive (defined
as $0.01) response. The mean ASC ratio (Table 2) or total
percentage of responders (Figure 1) stratified by time point, age
group and S. haematobium status is depicted. Upon examination of
all children, aged 4–14 years, regardless of schistosoma status, 47/
82 (57.3%) had a detectable MBC to AMA1 and 36/82 (43.9%) to
Table 1. Demographic characteristics at enrollment and features of P. falciparum clinical malaria episodes of Schistosoma
haematobium-positive and age-matched S. haematobium-negative Malian children contributing PBMC for immunologic analysis.
a
Category Age (years) S. haematobium (+) S. haematobium (2) P value
Mean age (n) All ages 8.7 (54) 9.0 (30) ns
4–8 6.4 (27) 6.8 (15) ns
9–14 11.0 (27) 11.3 (15) ns
Female (%) 4–14 26 (48.1) 16 (53.3) ns
Eggs (range)
a 4–14 58 (2–786) 0 n/a
4–8 51 (2–596) 0 n/a
9–14 66 (2–786) 0 n/a
Clinical malaria episodes
b (n,
range)
4–14 1.5 (1–4) 2.1 (1–4) 0.002
Days to first clinical malaria
episode
b (range)
4–14 76.2 (52–166) 26.4 (2–117) ,0.0001
c
Parasitemia
b,d (range) 4–14 9,299 (275–155,425) 11,785 (600–135,000) 0.87
aUrinary egg excretion detected in 10 ml of filtered morning urine.
bResults for children who did not develop malaria (n=14) are not included these calculations. If no statistical difference was noted between children in the 4–8 year old
category compared to the 9–14 year old category, the results were combined.
cMultivariable Cox regression analysis used controlling for age and schistosoma status.
dGeometric mean parasite density per mm
3.
doi:10.1371/journal.pone.0037868.t001
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had not acquired malaria, at any age group and in either season,
during the study period (Table S1). Nine months later at the dry
season follow-up, 49/82 (59.8%) had a detctable MBC to AMA1
and 36/82 (43.9%) to MSP1. When age groups were stratified by
season, children aged 4–8 years did not have marked differences in
MBC during the transmission season compared to children aged
9–14 years in either AMA1 [22/40 (55%) vs. 25/42 (59%)] or
MSP1 [17/40 (42.5%) vs. 21/42 (50%)]. Dry season analysis
revealed that whereas younger children had a slight decrease in
the number of responders with detectable malaria antigen-specific
MBC, a trend was noted towards a greater number of older
responders: AMA1 [20/40 (50%) vs. 29/42 (69%); P=0.08 b; x
2
analysis] or MSP1 [14/40 (35%) vs. 22/42 (52%); P=0.11; x
2
analysis]. Linear regression models expressing malaria antigen-
specific MBC as a function of age did not show significant
associations. Of those tested, 29 individuals (35%) had no
detectable MBC to either MSP1 or AMA1 at the wet season time
point despite documented evidence of malaria infection in 28
individuals [(SP=19 (36%); SN=10 (34%)]. At the dry season
follow-up period 6–9 months later, 12/29 [41% (or 15% of total
population)] remained without detectable MBC to either malaria
antigen [SP=6 (32%); SN=6 (60%); P=0.13; x
2 analysis]. Of
note, tetanus toxoid-specific MBC was examined in 20 children
(aged 4–14 years) in an effort to incorporate a positive
experimental control; however few positive responses were
detected. This lack of tetanus toxoid response was not the result
of technical issues since robust MBC were detected in a control
U.S. malaria-naı ¨ve volunteer with known tetanus toxoid boosting
2 years prior to PBMC collection who was tested simultaneously
(data not shown). The lack of detectable tetanus toxoid-specific
MBC likely represents predictable loss of MBC more than two
years following immunization [2], MBC below the level of
detection, or lack of immunization. Tetanus toxoid was not used
as a positive control in the remaining studies.
Children were next stratified by S. haematobium status and age
group. In general, the mean ASC ratio of detectable MBC was
increased in the transmission season as compared to the dry season
and in the SP group compared to the SN group. However, this was
only statistically significant in a few instances, notably between SP
children aged 4–8 years and aged 4–14 years after stimulation with
MSP1 when assessing the transmission season time point
compared to the dry season results. This observation did not hold
true for SP children aged 9–14 years. However, when analyzing
the number of children deemed to have a positive ASC response
($0.01), differences emerged upon age stratification. Whereas it
appeared that little difference was noted in the ASC responses
between SP and SN children when results were examined in
children between ages 4–14 years, SP children aged 9–14 years of
age exhibited significantly increased number of responders to both
AMA1 and MSP1 in the transmission season than did the SN
counterparts (AMA1:20/27 (74%) vs. 5/15 (33%), P=0.02;
MSP1:17/27 (64%) vs. 4/15 (27%), P=0.05) using Fischer’s
exact test (Figure 1C). Moreover, while the number of SP
responders in the transmission season remained the same or fell
slightly by the dry season follow-up, a notable increase in
responders was noted in the SN group upon dry season follow-
up (Figure 1C).
Table 2. Memory B cell (MBC) expressed as the mean number of malaria antigen specific SFC cells to apical membrane antigen
(AMA1) or merozoite surface protein 1 (MSP1) compared to total IgG SFC (i.e., ASC ratio) measured in children with (SP) or without
(SN) S. haematobium infection and stratified by age group and season (i.e., malaria transmission and dry season).
Malaria Antigen Age (years) Group
a MBC Transmission MBC Dry P value
b
AMA1 4–14 SP + SN 0.071 0.056 0.16
SP 0.085 0.061 0.08
SN 0.048 0.046 0.94
4–8 SP + SN 0.063 0.036 0.05
SP 0.070 0.045 0.11
SN 0.049 0.020 0.28
9–14 SP + SN 0.079 0.074 0.77
SP 0.096
c 0.074 0.35
SN 0.050 0.073 0.41
MSP1 4–14 SP + SN 0.026 0.024 0.69
SP 0.031 0.019 0.04
SN 0.017 0.033 0.15
4–8 SP + SN 0.019 0.009 0.07
SP 0.022 0.008 0.049
SN 0.013 0.011 0.86
9–14 SP + SN 0.032 0.038 0.53
SP 0.038 0.029 0.12
SN 0.023 0.054 0.12
aA total of 53 SP (26 aged 4–8 years, 27 aged 9–14 years) and 29 SN (14 aged 4–8 years, 15 aged 9–14 years) were examined in both the transmission and dry season
(Note: Sample for 1 SP and 1 SN were excluded from the wet and from the dry season for a total of 4 samples).
bStatistical analysis performed between transmission and dry season values using paired ttest (two-tailed). P value deemed statistically significant #0.05.
cStatistical significance measured between SP and SN values using the Mann Whitney test for values not normally distributed (P value #0.05).
ASC ratios $0.01 were defined as a positive specific MBC responses. Mean age-stratified group values $0.01 are depicted in bold font.
doi:10.1371/journal.pone.0037868.t002
B Memory Cells in Co-Infection
PLoS ONE | www.plosone.org 5 June 2012 | Volume 7 | Issue 6 | e37868Memory B Cell Response to S. haematobium Antigens
Paired PBMC sample obtained at two time points were
examined in SP and SN children (Table 3 and Figure 2). The
ASC ratio was calculated after measuring S. haematobium-specific
MBC to SEA and SWAP and expressed as a discreet value or as a
positive (.0.01) response. The mean ASC ratio (Table 3) or total
percentage of responders (Figure 2) stratified by time point, age
group and S. haematobium status is depicted. Detectable MBC were
significantly increased in SP children compared to SN children at
both time points, in all age strata and to both antigens with the
exception of children aged 4–8 years to SWAP (Figure 2). In
general, increased detection of MBC in SP during the dry season
SP MBC was noted in comparison to the transmission season and
this phenomenon was noted to be statistically significant in
younger children and in the group at large (aged 4–14 years) for
SEA while older SP children had enhanced MBC to SWAP
(Table 3). SEA appeared to elicit a more robust immune response
with significantly more responders to SEA than to SWAP in both
the transmission period and in the younger (4–8 years) age group.
Of those children with known S. haematobium infection, 17/53
(32%) had no detectable MBC to either schistosoma antigen at the
wet season time point. However, 11/17 (65%) developed
demonstrable MBC response by the dry season follow-up. MBC
to schistosoma antigens was detected in a small number of SN
children. Repeated urine tests (n=3) at screening were negative in
all SN children. A total of 4 SN (13%) children had detectable
MBC to SWAP and 7 SN (23%) children had MBC to SEA at the
dry season follow-up. In no instance did individuals with
detectable MBC to SWAP have detectable MBC to SEA (data
not shown). Only one child was found to have acquired S.
haematobium among the samples analyzed in this study, while the
remainder had repeated negative urine tests for egg excretion at
the dry season follow-up appointment. Correspondingly, this one
individual had an eight-fold rise in antibody titer to SWAP (dry
season titer=16,777) and an end-point titer of 66,187 to SEA by
the dry season follow-up.
Flow Cytometric Analysis of Expanded Cells
We collected flow cytometric data on a subset of 14 participants
(n=7 SP and 7 SN children) to evaluate the composition of cells
following in vitro expansion. We observed an increase in the
percentage of CD19
+CD3
2 (total B cells) in all children evaluated.
Pre-expansion total B cells were 13.8% (range 7.2–20.3%) of
PBMC examined. Of these, 18.1% (range 11.1–33.4%) were
Antibody-secreting plasmablasts/MBCs
(CD19
+CD27
+CD38
+CD3
2). Post-expansion we observed a
three-fold increase in the proportion of CD19
+CD3
2
(mean=37.6%; range 26.6–51.8%), of which a mean of 51.5%
(range 48.7–64.3%) were plasmablasts/MBCs
(CD19
+CD27
+CD38
hiCD3
2) (Figure S1).
Figure 1. B memory cell responders to P. falciparum antigens.
Shown are the percentages of B memory cell responders to P.
falciparum antigens, AMA1 and MSP1, as determined by ELISpot assay
during the malaria transmission season and again during the dry season
with significant differences demarcated. Results were stratified by age
(A–C) and S. haematobium status [S. haematobium positive (SP)=54 and
S. haematobium negative (SN)=29] Responders are defined as those
individuals with antigen specific cell (ASC) ratios (ratio of spot forming
cells (SFC)/10
6 expanded cells vs. total IgG SFC/10
6 cells) greater than
0.01.
doi:10.1371/journal.pone.0037868.g001
B Memory Cells in Co-Infection
PLoS ONE | www.plosone.org 6 June 2012 | Volume 7 | Issue 6 | e37868Antibody Response to Malaria and S. haematobium
Antigens
Paired sera sample obtained at two time points (wet season and
dry season) were examined for the presence of IgG antibody to all
four antigens (AMA1, MSP1, SEA and SWAP) (Table 4,
Figure 3A–D). Serum was available from 84 children during the
wet season and 82 during the dry season (2 sample did not have
enough to sera complete ELISA to all antigens). The geometric
mean (geomean) antibody titer for malaria antigens AMA1 and
MSP1 did not vary by schistosoma status or by season. All children
had measurable malaria antibody titers compared to U.S. malaria-
naı ¨ve adults [AMA1 range 500–49,474,000; MSP1 range 250–
1,222,076]. Malaria antibody titers were analyzed after stratifying
by age-group. Values were consistently lower in the younger group
(age 4–8 years) as compared to the older group (age 9–14 years),
however this was only statistically significant for MSP1 antibody
(Wet season geomean titer: 21,802 vs. 60,602, P=0.02; Dry
season geometric mean titer: 13,866 vs. 37,336, P=0.017).
Moreover, the significance was derived solely from SP children
(Wet season geomean titer: 12,904 vs. 69,902, P=0.005; Dry
season geomean titer: 11,317 vs. 48,220, P=0.009). No statistical
significance was noted in age-stratified SN children. This finding
also held true when evaluating the strength of the association
between antibody and age (converted to months; Table 4).
Statistically significant higher antibody titers of SEA and SWAP
were noted in SP children compared to SN children. Even
children deemed negative for S. haematobium were found to have
four-fold higher antibody titers than U.S. parasite-naı ¨ve adults
(Table 4). A strong correlation, utilizing Spearman rank correla-
tion coefficient, was noted between SEA antibody and the
induction of MBC response, while a more modest correlation
was noted between SWAP antibody and MBC response (Table 4).
When the strength of association was examined between antibody
response and age, a modest correlation was noted for SEA during
the wet season and SWAP during the dry season. However, when
we examined the strength of associations between antibody and
urinary egg secretion, we found a stronger association (SEA – wet
season: r=0.3552, 95% CI [0.0768–0.5822], P=0.01; dry
season: r=0.4462, 95% CI [0.1834–0.6494], P=0.001) and
(SWAP - wet season: r=0.3014, 95% CI [0.0167–0.5409],
P=0.03; dry season: r=0.4181, 95% CI [0.1498–0.6290],
P=0.003) suggesting that the burden of infection rather than
the child’s age predicted antibody production. In turn, egg
secretion did not correlate with MBC response to SWAP at any
time point and only modestly correlated to SEA during the wet
season (r=0.2984, 95% CI [0.0251–0.5302], P=0.03).
Linear regression models demonstrated a relatively modest
correlation between log-transformed mean antibody titers to
AMA1, MSP1 and SEA and antigen-specific MBC (Figure 3 A–
C). This was not significant for SWAP (Figure 3D). However, a
significant correlation was noted between the mean antibody titer
and the MBC response by Spearman rank correlation coefficient
for all 4 antigens tested (Table 4). In all cases the Spearman
coefficient (r) was higher during the wet season than the dry.
AMA1 appeared to have the strongest correlation during the wet
season (r=0.6567, P=,0.0001) while the dry season results for
SWAP had the weakest correlation (r=0.2616, P=0.02)
(Table 4).
In the face of markedly elevated antibody titers in SN children
to both schistosoma antigens in comparison to U.S. parasite-naı ¨ve
adults, we defined positive antibody responders for this endemic
region as individuals with an antibody titer .3 SE above the SN
mean (minus the top 10
th percentile of the SEA and SWAP
antibody titers). Based on these criteria, positive antibody
responses were titers of 2,880 and 1,825 for SEA and SWAP,
respectively. Of SN children, 6/30 (20%) had detectable antibody
titers to SEA and four of the six had detectable MBC. In regard to
SWAP, 5/30 (17%) SN children had detectable levels, only one of
whom had detectable MBC. In the SP cohort, 6/54 (11%) were
negative for antibody to SEA, of whom only one had detectable
MBC. In regard to SWAP, 11/54 (20%) were antibody negative,
of whom 3 had detectable MBC. Thus, within the defined
Table 3. Memory B cell (MBC) expressed as the mean number of Schistosoma haematobium-specific SFC to soluble egg antigen
(SEA) or soluble worm antigen protein (SWAP) compared to total IgG SFC measured in children with (SP) or without (SN)
S. haematobium infection and stratified by age group and season (i.e., malaria transmission and dry season).
Schistosoma Antigen Age (years) Group MBC Transmission MBC Dry P value
a
SWAP 4–14 SP 0.017
b 0.021
b 0.58
SN 0.004 0.005 0.68
4–8 SP 0.019 0.019
b 0.94
SN 0.003 0.003 0.98
9–14 SP 0.014
b 0.022
b 0.03
SN 0.007 0.006 0.62
SEA 4–14 SP 0.034
b 0.047
b 0.05
SN 0.006 0.012 0.11
4–8 SP 0.024
b 0.037
b 0.04
SN 0.005 0.015
c 0.18
9–14 SP 0.041
b 0.055
b 0.26
SN 0.005 0.009 0.44
aStatistical analysis performed between transmission and dry season values using the paired two-tailed ttest. P value deemed statistically significant #0.05.
bStatistical significance measured between SP and SN values using the Mann Whitney test for values not normally distributed (P value #0.05).
cThree of fifteen SN children had a positive response (ASC .0.01) to SEA. One child was subsequently determined to have acquired a S. haematobium infection in the
interim since screening. All other responders to SWAP or SEA had repeatedly negative urine analyses for egg excretion.
ASC ratios of .0.01 were defined as positive specific MBC responses. Mean age-stratified group values .0.01 are depicted in bold font.
doi:10.1371/journal.pone.0037868.t003
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a specificity of 80%. The sensitivity for SWAP was calculated to be
76% with a specificity of 83%.
Discussion
There is growing evidence that immunologic B cell memory,
albeit inefficient, develops to malaria blood-stage antigens [9–11],
but very little is known regarding the acquisition of memory to
other human parasitic infections or the immunologic perturbations
that one parasitic infection has upon the immune responsiveness to
another infection in the host. We demonstrate, for the first time,
MBC response to S. haematobium antigens in Malian children with
urinary egg excretion and provide evidence of seasonal acquisition
of immunologic memory, age-associated differences in MBC
acquisition, and correlation with circulating S. haematobium
antibody. While durable MBC to malaria antigens in young
children likely requires repeated infections with stepwise acquisi-
tion, we did not detect significant correlation of MBC to age over
the 4–14 year old age distribution of Malian children. However,
the presence of a parasitic co-infection resulted in older children
with underlying S. haematobium infection having significantly more
detectable MBC to malaria antigens (AMA1 and MSP1) than their
age-matched SN counterparts.
Studies have consistently demonstrated inefficient generation of
MBC across Africa and Southeast Asia to known blood-stage
malaria antigens and vaccine candidates, AMA1 and MSP1,
whether the analysis occurs in areas of high endemicity [9],
seasonal endemicity [11], or low endemicity [10]. Similarly, we
found comparable levels of antigen specific MBC in ,60% of
children to AMA1 and ,44% to MSP1. While we demonstrate a
trend towards a contraction of malaria antigen specific MBC
seasonally and an expansion of the MBC compartment with age,
this was only statistically significant for MSP1. Expansion of the
malaria MBC compartment with age has been described; the
greatest proportion of increases occur in individuals aged 18–25
years [11]; an age group which we did not examine. Stable
antibody development to malaria antigens was detected and did
not wane by the dry season follow-up. MSP1 antibody levels
modestly correlated with age and were noted to be significantly
higher in children aged 9–14 years, as compared to younger
children aged 4–8 years. No such correlation was noted for
AMA1. However, it is likely that a larger sample size might have
detected smaller differences. Parasite antibody levels correlated
modestly with MBC results, although we consistently noted that
about one third of children with known parasitic infection (malaria
or schistosomiasis), failed to mount any detectable MBC response.
Over the course of seasonal follow-up, two thirds of these non-
responders subsequently developed an MBC response. We
speculate that this may be reflective of ongoing parasitic exposure
and acquisition of memory. A longitudinal study with multiple
time points over the course of several transmission seasons might
be necessary to pinpoint the acquisition of memory to parasite
antigens upon repeated infections. Alternatively, our observations
Figure 2. B memory cell responders to S. haematobium antigens.
Shown are the percentages of B memory cell responders to S.
haematobium antigens, SEA and SWAP, as determined by ELISpot assay
during the malaria transmission season and again during the dry season
with significant differences demarcated. Results were stratified by age
(A–C) and S. haematobium status [S. haematobium positive (SP)=54 and
S. haematobium negative (SN)=29] Responders are defined to those
individuals with antigen specific cell (ASC) ratios (ratio of spot forming
cells (SFC)/10
6 expanded cells vs. total IgG SFC/10
6 cells) greater than
0.01.
doi:10.1371/journal.pone.0037868.g002
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malaria [38]. It is also important to recognize that detectable
MBC only reflect those in circulation at the time of specimen
collection and those that respond to the strain of antigen used in
stimulation, and may not represent the full sequestered MBC pool.
Immunologic MBC to S. haematobium, to our knowledge, has not
been reported. Evidence of age-acquired immunity to schistosoma
spp. does exist [39]. Studies examining the pathogenicity of
S. haematobium found C3d, a breakdown product of complement
C3, to be present in large quantities [40] and to correlate with egg
production in S. mansoni models [16]. C3d contains the ligand for
CD21, a B cell co-receptor, which would be expected to enhance
B cell signaling when co-ligated to the B cell antigen receptors
[41]. This might suggest that not only is the background milieu in
schistosoma infections conducive to MBC development, but that
non-specific bystander activation may induce enhanced response
to other antigens. Our studies demonstrate robust MBC response
in terms of both the numbers of responders and the magnitude of
MBC responses to schistosoma antigens in children with known
S. haematobium egg excretion as compared to SN children.
Antibody levels correlated with MBC and with age, particularly
for SEA. SEA is extremely immunogenic and generally elicited
more detectable MBC (over 80% in children aged 9–14 years by
the dry season time point) with higher ASC ratios (up to 0.055% of
total IgG) than was measured to SWAP. Seasonal increases in the
MBC compartment were noted to SEA in younger children aged
4–8 years and in the SP group in general. This was in contrast to
SWAP where older children, aged 9–14 years, were noted to have
seasonal acquisition (Table 3). It may be that SWAP is less
immunogenic and stepwise acquisition of MBC occurs whereas a
steady-state is achieved in older children in response to SEA.
Of note, 10–20% of SN children had evidence of MBC
responses and/or detectable antibody titers to SEA or SWAP
despite having repeated negative tests for egg excretion. There was
no correlation between children who developed a MBC response
to SEA compared to SWAP. However there appears to be an
association between the minority of children who developed a
MBC response to SEA and antibody elevation. One child was
determined to have acquired S. haematobium in the interim from
enrollment to dry season follow-up with corresponding increases in
serum antibody levels. Peak acquisition of schistosomiasis occurs
late in the dry season when standing water pools begin to dry,
Table 4. Geometric mean antibody titers (OD 450 nm) stratified by antigen, season and schistosoma status in children with (SP)
and without (SN) S. haematobium.
Cohort Season Antigen Ab Titer
c
SP vs. SN
P Value
a
Ab vs. MBC
(r)
c 95% CI
b P value
Ab vs. Age
(r)
c 95% CI
b P value
SP Wet AMA1 49,667 0.34 0.6567 0.5034–0.7699 ,0.0001 0.1497 20.0805–0.3648 0.19
SN 37,345
SP Dry 57,534 0.10 0.5229 0.3281–0.6750 ,0.0001 0.1767 20.0576–0.3926 0.13
SN 24,720
Negative
d 86
Positive
d 108,579
SP Wet MSP1 34,172 0.56 0.4131 0.2034–0.5866 0.0002 0.2639 0.0398–0.4636 0.02
SN 50,081
SP Dry 25,956 0.51 0.4046 0.1920–0.5808 0.0003 0.3077 0.0847–0.5013 0.006
SN 20,568
Negative 121
Positive 58,292
SP Wet SEA 25,539 ,0.0001 0.5785 0.4016–0.7138 ,0.0001 0.2910 0.0083–0.5306 0.03
SN 2,270
SP Dry 37,309 ,0.0001 0.5355 0.3343–0.6751 ,0.0001 0.1576 20.1317–0.4221 0.27
SN 2,859
Negative 473
Positive 8,521
SP Wet SWAP 4,511 ,0.0001 0.3108 0.0866–0.5051 0.006 0.1690 20.1201–0.4317 0.24
SN 818
SP Dry 7,238 ,0.0001 0.2616 0.0316–0.4653 0.02 0.2856 0.0025–0.5264 0.04
SN 858
Negative 126
Positive 3,612
aStatistical analysis performed between children with and without S. haematobium using the Mann Whitney test. P value deemed statistically significant #0.05.
Statistical analysis between transmission and dry season values is not shown but no statistical significance was noted.
b95% Confidence Interval of Spearman rank correlation test.
cAb refers to geometric mean antibody and age refers to age-in-months. Spearman rank correlation (r) is depicted.
dGeometric mean antibody titers are reported for negative controls (10 U.S. malaria naı ¨ve adult sera) and positive controls (10 pooled Malian adult sera).
Also depicted are geometric mean negative and positive control values for each antigen. Spearman rank correlation (r) testing and 95% confidence interval depicting
strength of association between antibody tested and MBC results as well as antibody tested and the child’s age in months.
doi:10.1371/journal.pone.0037868.t004
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transmission. We cannot rule out the possibility that children may
have had a previous S. haematobium infection and had been treated
prior to study enrollment (however routine testing and treatment
for individuals is uncommon until the regional population
prevalence reaches 40% and all guardians denied previous
infection in their children). Alternatively, children may have
cleared a previous asymptomatic infection, or even, possibly,
developed resistance to S. haematobium infection but remained free
of active infection with egg excretion.
We have previously documented an age-associated protective
effect against the acquisition of symptomatic malaria infection in
children aged 4–8 years with concomitant S. haematobium [20].
Furthermore, we have shown immunologic perturbation in co-
infected children including altered cytokine patterns, [25] and the
presence of T regulatory cells [42]. In the case of MBC specific to
malaria antigens, we noted a significant increase in detectable
MBC to both MSP1 and AMA1 in the older group of children. As
we have shown, an association exists between detectable MBC to
SEA and to age and also to egg production. It is possible that older
children have increased circulating C3d, which, in turn, stimulates
MBC development to malaria antigens via non-specific activation
of bystander B cells. Alternatively, the presence of S. haematobium
may influence hyperresponsivity to TLR9 during an acute malaria
infection. The immunosuppressive effect of parasitic infections
upon TLR-mediated phenomena is well established [19,43,44].
Contradicting these findings, S. mansoni-infected mice have
enhanced TLR9 responsiveness to SEA in bone marrow-derived
Th2-primed macrophages [17]. Moreover, innate immune
response to malaria infection is enhanced to TLR1, TLR2 and
TLR4 agonists [45], as well as TLR9 [46]. Given that MBC
stimulation can be driven by TLR4 and TLR9 [2], the presence of
circulating S. haematobium moieties may potentiate MBC response
to malaria antigens by a TLR pathway, primed to an acute
malaria infection.
In conclusion, we have found detectable MBC to both malaria
antigens and, for the first time, to schistosoma antigens and have
shown evidence of enhanced immunologic memory responses to
malaria antigens in children aged 9–14 years with S. haematobium
infection. While this does not explain our clinical findings
suggesting that S. haematobium confers an age-dependent protective
effect in children aged 4–8 years against malaria, it does further
emphasize the presence of strong immunologic interactions in co-
parasitic infections. Future longitudinal studies are needed to
further dissect the complexities of MBC development and to
determine the role, if any, that this immunologic phenomenon
plays in protection against malaria and the effect that TLR plays
in mediating immunologic responses to parasitic infections.
Supporting Information
Figure S1 Representative flow cytometry plots depict-
ing the gating strategy for detection of B cell memory
responses. Quantification of memory B cells (MBC) and MBC-
derived antigen-secreting cells (ASC, plasmablasts) with represen-
tative plots depicting the gating strategy. The percentages of gated
populations are denoted in the gated areas of each histogram.
Cells that were determined to be Vivid
-CD14
-CD3
-CD19
+ (Fig.
A–C) were then examined for the presence of CD38 and CD27.
Doublets and aggregates were gated out (histogram not shown).
Results pre- (Fig. D) and post- (Fig. E) PBMC expansion with
mitogens (pokeweed mitogen, b-mercaptoethanol, CpG-2006 and
Staphylococcus aureus Cowan) are depicted. CD27
+CD38
+ cells can
be divided into those determined to be CD38
hi (i.e., ASC/
plasmablasts depicted in the top half of the gates in panels D and
E) and CD38
dim (i.e., memory B cells depicted in bottom half of
gates in panels D and E). (Note: Data is reported as a combined
population to illustrate total in vitro expansion).
(TIF)
Table S1 Memory B cell (MBC) expressed as the mean
number of P. falciparum or S. haematobium antigen
specific MBC to apical membrane antigen (AMA1),
merozoite surface protein 1 (MSP1), soluble worm
antigen protein (SWAP), or soluble egg antigen (SEA)
compared to total IgG ASC (i.e., ASC ratio) measured in
children with S. haematobium (SP) infection with
malaria (SP Mal) or without malaria (SP no Mal)
infection. Results are stratified by age group and season (i.e.,
malaria transmission and dry season). ASC ratios $0.01 were
defined as a positive specific MBC responses. Mean age-stratified
group values $0.01 are depicted in bold font.
(DOC)
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